Alkem completes acquisition of Occlutech Holding AG

Listed Co AcquisitionStrategic Transactions View source PDF

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.5%1-day move

₹5545.50

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+2.5+0.7+1.2+1.6+1.3—————

Up moveDown movePending

AI summary

Alkem Laboratories said its wholly owned subsidiary Alkem Medtech has completed the acquisition of at least 51 percent and up to 55 percent equity in Switzerland based Occlutech Holding AG via a Share Purchase Agreement. Occlutech will now be a step-down subsidiary of Alkem. Earlier updates on this deal were shared on 13 February, 6 March, and 29 June 2026.

Likely market impact

Adds a new overseas subsidiary in the medical devices space, expanding Alkem's global footprint and product portfolio.